ADMA BIOLOGICS, INC.
ADMAUS売上高
$510M
百万USD
営業利益
$191M
百万USD
純利益
$147M
百万USD
ROE
30.8%
最新FY
EPS
$0.60
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-18M | - |
| FY2021 | Q2 | $18M | $-19M | $-0.15 |
| FY2021 | Q3 | $21M | $-18M | $-0.13 |
| FY2021 | FY | $81M | $-72M | $-0.51 |
| FY2022 | Q1 | $29M | $-25M | $-0.13 |
| FY2022 | Q2 | $34M | $-14M | $-0.07 |
| FY2022 | Q3 | $41M | $-15M | $-0.08 |
| FY2022 | FY | $154M | $-66M | $-0.33 |
| FY2023 | Q1 | $57M | $-7M | $-0.03 |
| FY2023 | Q2 | $60M | $-6M | $-0.03 |
| FY2023 | Q3 | $67M | $3M | $0.01 |
| FY2023 | FY | $258M | $-28M | $-0.13 |
| FY2024 | Q1 | $82M | $18M | $0.08 |
| FY2024 | Q2 | $107M | $32M | $0.13 |
| FY2024 | Q3 | $120M | $36M | $0.15 |
| FY2024 | FY | $426M | $198M | $0.81 |
| FY2025 | Q1 | $115M | $27M | $0.11 |
| FY2025 | Q2 | $122M | $34M | $0.14 |
| FY2025 | Q3 | $134M | $36M | $0.15 |
| FY2025 | FY | $510M | $147M | $0.60 |
| FY2026 | Q1 | $114M | $45M | $0.19 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | $81M | $154M | $258M | $426M | $510M |
| 営業利益 | $-17M | $-39M | $-60M | $-41M | $-65M | $-58M | $-39M | $22M | $139M | $191M |
| 純利益 | $-20M | $-44M | $-66M | $-48M | $-76M | $-72M | $-66M | $-28M | $198M | $147M |
| 総資産 | $24M | $108M | $89M | $127M | $208M | $276M | $348M | $329M | $489M | $624M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $-4M | $40M | $20M | $26M | $88M | $141M | $152M | $135M | $349M | $477M |
| 営業CF | $-18M | $-37M | $-63M | $-76M | $-102M | $-112M | $-60M | $9M | $119M | $50M |
| EPS | - | - | - | - | - | $-0.51 | $-0.33 | $-0.13 | $0.81 | $0.60 |
| BPS | $-0.35 | $0.89 | $0.43 | $0.30 | $0.73 | $0.72 | $0.68 | $0.59 | $1.47 | $2.00 |
| ROE | 437.8% | -108.5% | -332.5% | -184.3% | -85.8% | -50.8% | -43.4% | -20.9% | 56.6% | 30.8% |